Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines

Medicinal Chemistry

Volumn 9, Issue 5, 2013, Pages 633-641

  Sova, Matej ^a   Žižak, Željko ^b   Stanković, Jelena A Antić ^c   Prijatelj, Matevž ^a   Turk, Samo ^a   Juranić, Zorica D ^b   Mlinarič Raščan, Irena ^a   Gobec, Stanislav ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anticancer drug discovery; Antineoplastic drug; Cinnamates; Cytotoxicity

Indexed keywords

CINNAMIC ACID DERIVATIVE;

ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; K562 CELLS; MCF-7 CELLS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84883369542     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411309050002     Document Type: Article

References (49)

1. Hoskins, J.A. The occurrence, metabolism and toxicity of cinnamic acid and related compounds. J. Appl. Toxicol., 1984, 4, 283-92.
2. Lafay, S.; Gil-Izquierdo, A. Bioavailability of phenolic acids. Phytochem. Rev., 2008, 7, 301-11.
3. Clifford, N.M. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J. Sci. Food Agric., 1999, 79(3), 362-72.
4. Clifford, N.M. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolism. J. Sci. Food Agric., 2000, 80(7), 1033-43.
5. Simonyan, A.V. Activity of cinnamic acid derivatives and new methods of their synthesis (a review). Khim.-Farm. Zh., 1993, 27(2), 21-2.
6. Sharma, P. Cinnamic acid derivatives: A new chapter of various pharmacological activities. J. Chem. Pharm. Res., 2011, 3(2), 403-23.
7. De, P.; Baltas, M.; Bedos-Belval, F. Cinnamic acid derivatives as anticancer agents-A review. Curr. Med. Chem., 2011, 18, 1672-1703.
8. Narasimhan, B.; Belsare, D.; Pharande, D.; Mourya, V.; Dhake, A. Esters, amides and substituted derivatives of cinnamic acid: synthesis, antimicrobial activity and QSAR investigations. Eur. J. Med. Chem., 2004, 39(10), 827-34.
9. Carvalho, S.A.; da Silva, E.F.; de Souza, M.V.N.; Lourenco, M.C.S.; Vicente, F.R. Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives. Bioorg. Med. Chem. Lett., 2008, 18(2), 538-41.
10. Tonari, K.; Mitsui, K.; Yonemoto, K. Structure and antibacterial activity of cinnamic acid related compounds. J. Oleo Sci., 2002, 51(4), 271-73.
11. Kumar, D.; Judge, V.; Narang, R.; Sangwan, S.; De Clercq, E.; Balzarini, J.; Narasimhan, B. Benzylidene/2-chlorobenzylidene hydrazides: Synthesis, antimicrobial activity, QSAR studies and antiviral evaluation. Eur. J. Med. Chem., 2010, 45(7), 2806-16.
12. Bailly, F.; Cotelle, P. Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet. Curr. Med. Chem., 2005, 12(15), 1811-18.
13. Jarvest, R.L.; Pinto, I.L; Ashman, S.M.; Dabrowski, C.E.; Fernandez, A.V.; Jennings, L.J.; Lavery, P.; Tew, D.G. Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones. Bioorg. Med. Chem. Lett., 1999, 9(3), 443-8.
14. Jain, A.K.; Mehta, S.C.; Shrivastava, N.M. Synthesis, structure elucidation and antimicrobial activity of N-substituted α-benzamido- β-[3-methoxy-4-(p-toluene sulfonyloxy)]-cinnamamides. Asian J. Chem., 2004, 16(1), 357-64.
15. Mahajan, R.P.; Patil, U.K.; Patil, S.L. A facile microwave assisted synthesis and antimicrobial activities of naturally occurring (E)-cinnamyl (E)-cinnamates and (E)-aryl cinnamates. Indian J. Chem. B Org., 2007, 46(9), 1459-65.
16. Bisogno, F.; Mascoti, L.; Sanchez, C.; Garibotto, F.; Giannini, F.; Kurina-Sanz, M.; Enriz, R. Structure-antifungal activity relationship of cinnamic acid derivatives. J. Agric. Food Chem., 2007, 55(26), 10635-40.
17. Zhu, J.; Zhu, H.; Kobamoto, N.; Yasuda, M.; Tawata, S. Fungitoxic and phytotoxic activities of cinnamic esters and amides. J. Pestic. Sci. Soc. Jpn., 2000, 25(3), 263-6.
18. Wiesner, J.; Mitsch, A.; Wissner, P.; Jomaa, H.; Schlitzer, M. Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg. Med. Chem. Lett., 2001, 11(3), 423-4.
19. Gupta, A.K.; Soni, L.K.; Hanumantharao, P.; Sambasivarao, S.V.; Babu, M.A.; Kaskhedikar, S.G. 3D-QSAR analysis of some cinnamic acid derivatives as antimalarial agents. Asian J. Chem., 2004, 16(1), 67-73.
20. Lee, S.; Han, J.-M.; Kim, H.; Kim, E.; Jeong, T.-S.; Lee, W.S.; Cho, K.-H. Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, acyl-CoA: cholesterol acyltransferase-1 and -2 activity, and decrease of HDL-particle size. Bioorg. Med. Chem. Lett., 2004, 14(18), 4677-81.
21. Shahidi, F.; Chandrasekara, A. Hydroxycinnamates and their in vitro and in vivo antioxidant activies. Phytochem. Rev., 2010, 9, 147-170.
22. Natella, F.; Nardini, M.; Di Felice, M.; Scaccini, C. Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation. J. Agric. Food Chem., 1999, 47(4), 1453-9.
23. Kancheva, V.D. Phenolic antioxidants - radical-scavenging and chain-breaking activity: A comparative study. Eur. J. Lipid Sci. Technol., 2009, 111, 1072-89.
24. Lee, M.-K.; Park, Y.B.; Moon, S.-S.; Bok, S.H.; Kim, D.-J.; Ha, T.-Y.; Jeong, T.-S.; Jeong, K.-S.; Choi, M.-S. Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl)propanoic acid derivatives in high-cholesterol fed rats. Chem.-Biol. Interact., 2007, 170(1), 9-19.
25. Pérez-Alvarez, V.; Bobadilla, R.A.; Muriel P. Structure- hepatoprotective activity relationship of 3,4-dihydroxycinnamic acid (caffeic acid) derivatives. J. Appl. Toxicol., 2001, 21(6), 527-31.
26. Park, E.J.; Lee, S.; Jeong, T.S.; Bok, S.H.; Lee, M.K.; Park, Y.B.; Choi, M.S. Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats. J. Biochem. Mol. Toxicol., 2004, 18(5), 279-87.
27. Fernández-Martínez, E.; Bobadilla, R.A.; Morales-Ríos, M.S.; Muriel, P.; Pérez-Alvarez, V.M. Trans-3-phenyl-2-propenoic acid (cinnamic acid) derivatives: structure-activity relationship as hepatoprotective agents. Med. Chem., 2007, 3(5), 475-9.
28. Liu, I.M.; Hsu, F.L; Chen, C.F.; Cheng, J.T. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br. J. Pharmacol., 2000, 129(4), 631-6.
29. Neogi, P.; Lakner, F.J.; Medicherla, S.; Cheng, J.; Dey, D.; Gowri, M.; Nag, B.; Sharma, S.D.; Pickford, L.B.; Gross, C. Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents. Bioorg. Med. Chem., 2003, 11(18), 4059-67.
30. Ohnishi, M.; Matuo, T.; Tsuno, T.; Hosoda, A.; Nomura, E.; Taniguchi, H.; Sasaki, H.; Morishita, H. Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice. Bio Factors, 2004, 21, 315-9.
31. Adisakwattana, S.; Sookkongwaree, K.; Roengsumran, S.; Petsom, A.; Ngamrojnavanich, N.; Chavasiri, W.; Deesamer, S.; Yibchokanun, S. Structure-activity relationships of trans-cinnamic acid derivatives on alpha-glucosidase inhibition. Bioorg. Med. Chem. Lett., 2004, 14(11), 2893-6.
32. Adisakwattana, S.; Moonsan, P.; Yibchok-Anun, S. Insulinreleasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J. Agric. Food Chem,. 2008, 56(17), 7838-44.
33. Gobec, S.; Sova, M.; Kristan, K.; Lanišnik Rižner, T. Cinnamic acid esters as potent inhibitors of fungal 17beta-hydroxysteroid dehydrogenase-a model enzyme of the short-chain dehydrogenase/reductase superfamily. Bioorg. Med. Chem. Lett., 2004, 14(15), 3933-6.
34. Sova, M.; Perdih, A.; Kotnik, M.; Kristan, K.; Lanišnik Rižner, T.; Šolmajer, T.; Gobec, S. Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study. Bioorg. Med. Chem., 2006, 14(22), 7404-18.
35. Kristan, K.; Starčević, Š.; Brunskole, M.; Lanišnik Rižner, T.; Gobec, S. Cinnamates and cinnamamides inhibit fungal 17betahydroxysteroid dehydrogenase. Mol. Cell. Endocrinol., 2006, 248(1-2), 239-41.
36. Kristan, K.; Bratkovič, T.; Sova, M.; Gobec, S.; Preželj, A.; Urleb, U. Novel inhibitors of beta-ketoacyl-ACP reductase from Escherichia coli. Chem.-Biol. Interact., 2009, 178(1-3), 310-6.
37. Montalbetti, C.A.G.N.; Falque, V. Amide bond formation and peptide coupling. Tetrahedron, 2005, 61(46), 10827-52.
38. Payne, C.S.; Saeed, M.; Wolfe, A.D. Ligand stabilization of cholinesterases. Biochim. Biophys. Acta, 1989, 999(1), 46-51.
39. Diaz-Perez, J.L.; Jordon, R.E. The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid. Clin. Immunol. Immunopathol., 1976, 5, 360-70.
40. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2), 55-63.
41. Ohno, M.; Abe, T. Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J. Immunol. Methods 1991, 145(1-2), 199-203.
42. Boström, J.; Greenwood, J.R.; Gottfries, J. Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J. Mol. Graph. Model., 2003, 21, 449-62.
43. Grant, J.A.; Gallardo, M.A.; Pickup, B.T. A fast method of molecular shape comparison. A simple application of a Gaussian description of molecular shape. J. Comput. Chem., 1996, 17, 1653-66.
44. Tanrikulu, Y.; Nietert, M.; Scheffer, U.; Proschak, E.; Grabowski, K.; Schneider, P.; Weidlich, M.; Karas, M.; Göbel, M.; Schneider, G. Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targets. ChemBio Chem 2007, 8(16), 1932-6.
45. Juranić, Z.D.; Nesković-Konstantinović, Z.; Stanojković, T.P.; Žižak, Ž.; Srdič, T.; Stanojević-Bakić, N.; Milošević, D.; Jovanović, D. The antitumor immune response in HER-2 positive, metastatic breast cancer patients. J. Transl. Med., 2005, 3, 13-9.
46. Krsti ć, N.M.; Bjelakovi ć, M.S.; Žižak, Ž.; Pavlovic ć, M.D.; Juranic ć, Z.D.; Pavlovic ć, V.D. Synthesis of some steroidal oximes, lactams, thiolactams and their antitumor activities. Steroids, 2007, 72(5), 406-14.
47. Jin, G.; Zhang, T.; Wang, T.; Yang, L.P. Inhibition of alphainterferon and cinnamic acid on proliferation of human lung cancer cell. Ai Zheng, 2002, 21(8), 860-2.
48. Ekmekcioglu, C.; Feyertag, J.; Marktl, W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells. Cancer Lett., 1998, 128, 137-44.
49. Dornish, J.M.; Pettersen, E.O.; Oftebro, R. Synergistic cell inactivation of human NHIK 3025 cells by cinnamaldehyde in combination with cis-diamminedichloroplatinum(II). Cancer Res., 1988, 48(4), 938-42.